Table 2.
Category 2: Lymphoma vs. other malignancies (n=3) | ||||||
---|---|---|---|---|---|---|
Age | Sex | Site LN | FNA Dx | HPE | Error type | Cause of Error |
50 | M | Cx | NHL, HG | Small-cell carcinoma metastatic | I | Low cellularity, crush artifact |
62 | M | Cx | NHL | Carcinoma, Metastatic | I | Crush artifact |
37 | M | Cx | NHL, HG | Nasopharyngeal Carcinoma, Metastatic | I | |
Category 3: Hodgkin vs. non-Hodgkin lymphoma (n=7) | ||||||
65 | M | Cx | HL | DLBCL | I | Low cellularity, few atypical cells |
2 | F | SM | HL | DLBCL | I | Low cellularity |
65 | F | SC | HL | ALCL | I | Low cellularity |
47 | M | RPN | NHL, s/o ALCL | HL, NOS | I | Segmental involvement |
42 | M | Cx | NHL, s/o ALCL | HL, NS | I,S | Low cellularity, segmental involvement |
32 | M | Ax | NHL, s/o ALCL | HL, NS | I,S | Low cellularity, segmental involvement |
43 | F | Cx | NHL, s/o ALCL | HL, NS | I,S | Low cellularity, segmental involvement |
ALCL, Anaplastic large-cell lymphoma; Ax, Axillary; Cx, cervical; DLBCL, Diffuse large B-cell lymphoma; Dx, Diagnosis; F, Female; FL, Follicular lymphoma; HG, High grade; HL, Hodgkin lymphoma; HPE, Histopathological examination; I, Interpretation; LN, Lymph node; M, Male; NHL, Non-Hodgkin lymphoma; NOS, Not otherwise specified; RPN, Retroperitoneal; S, sampling ; SM, Sub-mandibular; S/O, Suggestive of; SC, Supraclavicular